跳至主要内容
临床试验/NCT01904045
NCT01904045已完成不适用

A Multicentre, Prospective, Non-Interventional Study to Assess the Intra-patient Variability of Tacrolimus Once and Twice Daily After Kidney Transplantation

Technical University of Munich1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2013年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
51
试验地点
1
主要终点
Intrapatient variability of tacrolimus through level

研究概览

简要总结

Aim of this study is to investigate whether in patients following kidney transplantation (>6 months after transplantation), the intra-patient variability of levels of tacrolimus is comparable after administration of tacrolimus twice daily (Prograf) to tacrolimus once daily (Advagraf), with each regimen for 3 months.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • signed written informed consent
  • male or female patient ≥ 18years of age
  • Patient has received a kidney transplantation at least 6 months prior to inclusion into the study
  • No acute rejection episodes for at least 3 months
  • PRG through level and dosing stable for at least 1 month
  • Patient is capable of understanding the purpose and risks of the study, has been fully informed and has given written informed consent to participate in the study

排除标准

  • Acute rejection episodes within the last 3 months prior to study entry
  • Unstable PRG trough level or dose change in the month before study entry
  • History of noncompliance to medical regimens
  • Patients unwilling to or unable to comply with the protocol
  • Treatment with another investigational product during this study or during the last 30 days prior to study start

结局指标

主要结局

Intrapatient variability of tacrolimus through level

时间窗: pre-dose, 1 h post dose and 3 h post dose for 3 month

次要结局

未报告次要终点

研究者

发起方
Technical University of Munich
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验